All studies
CompletedObservational

SYMPLIFY – assessing a multi-cancer early detection test in individuals referred with signs and symptoms of cancer

Catching cancer early makes it much easier to treat. Currently, the NHS uses urgent referral routes to investigate possible cancer symptoms quickly, but this requires many tests for people who turn out not to have cancer. The SYMPLIFY study is testing a new blood test called Galleri, which looks for tiny traces of cancer DNA in the bloodstream. The study is for adults referred by their GP for urgent cancer checks involving the gut, lungs, or gynaecological system, or through rapid diagnostic clinics. Taking part does not change your normal NHS care or treatment. You simply give one blood sample during a routine hospital appointment and allow researchers to review your medical records later. Researchers hope this simple test will help the NHS find cancers faster and more accurately in the future, saving lives and reducing unnecessary worry.

At a glance

Status
Completed
Sponsor
University of Oxford
Enrolment target
6,000
Start
05 Jul 2021
Estimated completion
30 Nov 2021

What is this study about?

Finding cancer early is one of the best ways to successfully treat it. When you have symptoms that could be linked to cancer, your GP might send you on an urgent NHS referral route so hospital specialists can investigate quickly. While this helps catch many cancers, it also means a lot of people have to undergo scans and tests before finding out they are completely clear. This process can cause worry and puts heavy demand on NHS hospitals.

Researchers know that growing cancers often shed tiny pieces of their genetic material, or DNA, directly into the bloodstream. Scientists have developed a new multi-cancer blood test that looks for these signs. The SYMPLIFY study aims to find out how accurate and helpful this blood test is when used in people who already have symptoms that might be caused by cancer.

By comparing the blood test results with your standard hospital tests, the study team hopes to learn whether this test can reliably detect cancers earlier. In the long run, this could lead to simpler, quicker checks for patients across the UK and help doctors spot cancers before they have a chance to spread.

Key takeaways

  • The SYMPLIFY trial tests a new blood test designed to spot multiple types of cancer early.
  • It is for adults referred by their GP for urgent investigations of potential cancer symptoms.
  • Taking part requires just one blood sample, usually taken during an existing hospital visit.
  • Your standard NHS care and investigations will continue exactly as normal.
  • The study aims to help the NHS make cancer diagnosis faster, simpler, and more accurate in the future.

Who may be eligible?

This study is open to adults aged 18 and older who have been urgently referred by their GP for hospital tests to check for possible cancer. This includes people sent to Rapid Diagnostic Clinics or those on an urgent two-week referral pathway for lung, gynaecological, or digestive system symptoms (such as stomach or bowel problems).

You will not be able to join the study if you have been diagnosed with or treated for an invasive cancer or blood cancer within the past three years (though certain hormone therapies are allowed). You also cannot take part if you are taking specific medications that affect cell growth, such as methotrexate, or if you have previously given blood for another GRAIL research trial.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am aged 18 or older.
  2. My GP has referred me for urgent hospital tests to check possible cancer symptoms (e.g. lung, gut, or gynaecological).
  3. I have not had invasive cancer or blood cancer in the last 3 years.
  4. I am not currently taking medicines like methotrexate or chemotherapy.
  5. I have not previously given blood for another GRAIL study.
Answer every question to see your result.

What does participation involve?

Taking part in the study is straightforward and will not disrupt your regular healthcare. You will not need any extra hospital visits. During an appointment you are already attending for your routine diagnostic tests, a nurse or researcher will ask for your consent and take a single blood sample. Where possible, they will take this sample at the same time as your routine blood tests to avoid an extra needle prick. You will not be given any study drugs or experimental treatments. After your visit, researchers will look at your NHS medical notes over the following months to see what tests you had and whether cancer was found. Your participation lasts for this single hospital visit, followed by background reviews of your records.

Potential risks and benefits

Taking part in this study will not directly change your current diagnosis or treatment, but your help could improve cancer detection for many people in the future. The physical risks are very low and similar to having any normal blood test, such as mild bruising, brief discomfort, a feeling of light-headedness, or a very small risk of infection where the needle enters your arm. Your routine NHS care will carry on exactly as planned regardless of whether you join. Taking part is completely voluntary, and you are free to change your mind and withdraw from the study at any time without it affecting your medical care.

Locations (14)

  • Southampton General Hospital
    Approximate
    Southampton, England
  • Buckinghamshire Healthcare NHS Trust
    City only
    Aylesbury, England
  • Churchill Hospital
    Approximate
    Oxford, England
  • Royal Berkshire Hospital
    Approximate
    Reading, England
  • Basildon and Thurrock University Hospital
    City only
    Basildon, England
  • Torbay & South Devon Foundation Trust
    Unverified
    Torquay, England
  • Royal Cornwall Hospital
    Unverified
    Truro, England
  • Royal Free Hospital
    Unverified
    London, England
  • University College London Hospital
    Unverified
    London, England
  • North Middlesex University Hospital NHS Trust
    Unverified
    London, England
  • York Hospital
    Unverified
    York, England
  • Hull University Teaching Hospitals NHS Trust
    Unverified
    Hull, England

Common questions

Will this test tell me immediately if I have cancer?

No. The blood sample is being tested for research purposes only. Your doctors will rely entirely on your standard NHS hospital tests to give you your diagnosis.

Will taking part delay my normal hospital tests?

Not at all. You will have all your usual NHS appointments, scans, and treatments exactly as scheduled.

Do I have to take any new medications?

No. The study only involves giving a single blood sample and sharing access to your health records. No new medications or treatments are involved.

Will I have to travel for extra appointments?

No. The research blood sample is taken during a hospital visit you are already attending for your standard care.

Can I leave the study if I change my mind?

Yes, you can withdraw at any time. Doing so will not affect your relationship with your healthcare team or the quality of your care.

How to find out more

Sarah Pearson

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.